TC BioPharm Company

TC BioPharm’s mission is to develop and commercialise innovative cell-based products to treat disease, improving patient health and Quality of Life.
TC BioPharm is a clinical development company with a cell-based product pipeline capable of treating a variety of disorders including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell®, in renal cell cancinoma, non-small cell lung cancer and melanoma patients.
Technology: Cell Therapies
Industry: Personalized Medicine
Headquarters: Holytown, North Lanarkshire, United Kingdom
Founded Date: 2013
Employees Number: 11-50
Funding Status: N/A

Visit Website
Register and Claim Ownership